| Title |
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
|
|---|---|
| Published in |
Trials, June 2010
|
| DOI | 10.1186/1745-6215-11-70 |
| Pubmed ID | |
| Authors |
Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE), Giovanni FM Strippoli |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| France | 1 | 1% |
| Australia | 1 | 1% |
| Unknown | 88 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 15% |
| Student > Master | 9 | 10% |
| Student > Bachelor | 9 | 10% |
| Student > Ph. D. Student | 7 | 8% |
| Other | 6 | 7% |
| Other | 22 | 24% |
| Unknown | 24 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 37% |
| Nursing and Health Professions | 10 | 11% |
| Agricultural and Biological Sciences | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Neuroscience | 2 | 2% |
| Other | 11 | 12% |
| Unknown | 26 | 29% |